Allergy Asthma Immunol Res.  2019 May;11(3):438-440. 10.4168/aair.2019.11.3.438.

Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation

Affiliations
  • 1Allergy Center, Saitama Medical University Hospital, Saitama, Japan. skikkawa@saitama-med.ac.jp
  • 2Department of Respiratory Medicine, Saitama Medical University Hospital, Saitama, Japan.
  • 3Department of Otorhinolaryngology, Saitama Medical University Hospital, Saitama, Japan.
  • 4Department of Otolaryngology, Chigasaki Central Hospital, Kanagawa, Japan.
  • 5Department of General Internal Medicine, Saitama Medical University Hospital, Saitama, Japan.

Abstract

No abstract available.


MeSH Terms

Asian Continental Ancestry Group*
Asthma*
Cryptomeria*
Humans
Rhinitis, Allergic, Seasonal*
Sublingual Immunotherapy*

Reference

1. Kim JH, Ye YM, Ban GY, Shin YS, Lee HY, Nam YH, et al. Effects of immunoglobulin replacement on asthma exacerbation in adult asthmatics with IgG subclass deficiency. Allergy Asthma Immunol Res. 2017; 9:526–533.
Article
2. Cho YS. Effective strategies for managing asthma exacerbations for precision medicine. Allergy Asthma Immunol Res. 2017; 9:463–465.
Article
3. Hojo M, Ohta K, Iikura M, Hirashima J, Sugiyama H, Takahashi K. The impact of co-existing seasonal allergic rhinitis caused by Japanese cedar pollinosis (SAR-JCP) upon asthma control status. Allergol Int. 2015; 64:150–155.
Article
4. Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, et al. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. 2015; 166:177–188.
Article
5. Yamanaka K, Shah SA, Sakaida H, Yamagiwa A, Masuda S, Mizutani H, et al. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen. Allergol Int. 2015; 64:54–59.
Article
6. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180:59–99.
7. Marogna M, Spadolini I, Massolo A, Berra D, Zanon P, Chiodini E, et al. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol. 2009; 102:69–75.
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr